Y mAbs Therapeutics (NASDAQ:YMAB) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James Healy Other companies: Seaport Therapeutics, Inc. (Director · Since at least Apr 30, 2026); BioAge Labs, Inc. (Director · Since at least Sep 25, 2024); Rapport Therapeutics, Inc. (Director · Since at least Jun 6, 2024); ArriVent BioPharma, Inc. (Director · Since at least Jan 25, 2024); CinCor Pharma Inc (Director · Jan 6, 2022 – Nov 28, 2022 · Past); Bolt Biotherapeutics, Inc. (Director · Feb 4, 2021 – Jun 12, 2024 · Past); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Mar 18, 2024 · Past); Coherus Oncology, Inc. (Director · May 22, 2019 – Jan 7, 2022 · Past); Natera, Inc. (Director · Sep 14, 2018 – Apr 25, 2025 · Past) | Director · Since at least Jun 12, 2019 |
| David Gill Other companies: Telix Pharmaceuticals Limited (Chair & Independent Non-Executive Director · Since at least May 11, 2026); Evolus, Inc. Common Stock (Director · Since at least Feb 12, 2018); Strongbridge Biopharma plc (Director · Sep 3, 2019 – Oct 5, 2021 · Past); STRATA Skin Sciences, Inc. (Director · May 30, 2018 – Nov 22, 2019 · Past); Melinta Therapeutics Inc (Director · May 25, 2018 – Jun 11, 2019 · Past); Ocugen, Inc. (Director · Dec 9, 2016 – Jun 15, 2018 · Past); Cempra Inc (Director · Jan 1, 2016 – Jan 3, 2017 · Past); EndoChoice Holdings Inc (President and CFO · Aug 14, 2015 – Nov 22, 2016 · Past) | Director · Since at least Sep 20, 2018 |
| Peter P Pfreundschuh Other companies: Voyager Therapeutics, Inc. (Chief Financial Officer · Sep 19, 2022 – Feb 21, 2024 · Past); Korro Bio, Inc. (Chief Financial Officer · Dec 1, 2020 – Feb 18, 2022 · Past); UroGen Pharma Ltd. (Chief Financial Officer · Jan 1, 2019 – Oct 15, 2020 · Past); Sucampo Pharmaceuticals Inc (CFO · Mar 20, 2017 – Feb 13, 2018 · Past); Immunomedics Inc (Chief Financial Officer · Aug 20, 2015 – Aug 20, 2015 · Past) | EVP, CFO and Treasurer · Since at least Jun 28, 2024 |
| Mary Tagliaferri Other companies: ADARx Pharmaceuticals, Inc. (Chief Medical Officer and SVP at Nektar Therapeutics · Since at least Sep 24, 2026); RayzeBio, Inc. (Director · Sep 14, 2023 – Feb 26, 2024 · Past); Enzo Biochem Inc (Director · Nov 17, 2020 – Jan 31, 2024 · Past) | Director · Feb 29, 2024 – Jun 11, 2024 · Past |
| Gérard Ber Other companies: Lantheus Holdings, Inc. (Director · Since at least May 6, 2022) | Director · Jul 15, 2022 – Jun 10, 2024 · Past |
| Michael J Rossi Other companies: Mirion Technologies, Inc. (Medical Group President · Nov 1, 2023 – Nov 1, 2023 · Past) | PRESIDENT & CEO, Director · Since at least Nov 6, 2023 |
| Biotech ApS WG | Director · Since at least May 15, 2023 |
| Bo Kruse | EVP, CFO, SECRY & TREAS. · Sep 20, 2018 – May 30, 2024 · Past |
| Douglas J Gentilcore | SVP, Danyelza Bus. Unit Head · Since at least Sep 16, 2025 |
| Gregory S Raskin | Director · Sep 20, 2018 – Aug 29, 2019 · Past |
| Johan Wedell-Wedellsborg | Director · Since at least Sep 20, 2018 |
| John LaRocca | SVP, General Counsel & Secry · Since at least Sep 16, 2025 |
| Pedro Claus Juan Moller-San | Director and CEO, Director · Sep 20, 2018 – Dec 14, 2021 · Past |
| Philip Karl Herman | SVP & CCO · Jan 1, 2020 – Dec 15, 2020 · Past |
| Steen Lisby | SVP & CHIEF SCIENTIFIC OFFICER · Jan 18, 2024 – Jan 18, 2024 · Past |
| Susan Laura Smith | SVP & CHIEF COMMERCIAL OFFICER · Dec 14, 2021 – Mar 5, 2024 · Past |
| Torben Lund-Hansen | SVP & CHIEF TECHNICAL OFFICER · Apr 26, 2022 – Aug 28, 2024 · Past |
| Vignesh Rajah | SVP & CHIEF MEDICAL OFFICER · Jun 2, 2020 – Mar 5, 2024 · Past |